Test draft just playing around

Posted by Mohit Khera, MD, MBA, MPH | May 2016

Mohit Khera, MD, MBA, MPH, presented “Test draft just playing around” during the 42nd Annual Ralph E. Hopkins Urology Seminar on February 1, 2023, in Jackson Hole, Wyoming.

How to cite: Khera, Mohit. “Test draft just playing around.” February 1, 2023. Accessed Apr 2024. https://grandroundsinurology.com/test-draft-just-playing-around/

Test draft just playing around – Summary

apies as first line therapies; urethral suppositories, injectables, and vacuum pumps as second-line therapies; and penile implants and corrective vascular surgery as third-line therapies. In the new model, physicians should first counsel patients on all the options available, clearly laying out the benefits and risks of each, and let them decide what the first-line treatment should be. However, as part of that counseling, physicians should stress the importance of lifestyle changes in improving sexual function that could negate the need for any potentially risky intervention. The same goes for the option of mental health referrals and sex therapy. Another paradigm shift represented in the 2018 guidelines w

About The 42nd Annual Ralph E. Hopkins Urology Seminar:

The Ralph E. Hopkins Urology Seminar is a multi-day meeting focused on training urologists in the latest in assessing, diagnosing, and treating urologic conditions in the clinical setting. Updates are provided on urologic cancers, stone disease, urologic reconstruction, female urology, infertility, sexual function, emerging surgical techniques, and general urology. The 42nd iteration of the meeting took place from February 1st to 4th, 2023, in Jackson Hole, Wyoming.

For further educational activities from this conference, visit our collection page.

About The Author

Mohit Khera, MD, MBA, MPH

Mohit Khera, MD, MBA, MPH, is a board-certified urologist specializing in male infertility, male and female sexual dysfunction, and declining testosterone levels in aging men. Dr. Khera’s research focuses on the efficacy of botulinum toxin type A in treating Peyronie’s disease as well as genetic and epigenetic studies on post-finasteride syndrome patients and testosterone-replacement therapy. Dr. Khera earned his MBA and MPH from Boston University before earning his MD from the University of Texas Medical School at San Antonio. Dr. Khera completed his urology residency training in the Scott Department of Urology at Baylor College of Medicine (BCM) where he also completed a one-year general surgery internship. After completing his urology residency, he went on to complete a one-year fellowship in Male Reproductive Medicine and Surgery at BCM. Currently Dr. Khera is a professor in the Scott Department of Urology at Baylor College of Medicine, and he holds the F. Brantley Scott Chair in urology. Dr. Khera also serves as the director of the Laboratory for Andrology Research, the medical director of the Baylor Executive Health Program and the medical director of the Scott Department of Urology. He also serves as president of the Sexual Medicine Society of North America. Dr. Khera has initiated numerous FDA-approved clinical trials. His scientific and clinical experiences have allowed him to thus far give over 400 lectures at scientific meetings throughout the world, publish over 160 articles in peer-reviewed journals, complete 15 book chapters, and edit and write two books in the field of sexual medicine and men’s health. Dr. Khera shares his time and knowledge with the general public. He has been voted several times as one of Houston’s Best Doctors by Health and Sport Fitness Magazine and by Houstonia Magazine and is a frequent guest on such TV programs as Fox News’ “Ask theDoctor.” He also writes a blog on men’s health for the Houston Chronicle newspaper.

Join the GRU Community

- Why Join? -

Share This

Chat with usLiveChat